ATM and leukemia: As demonstrated by Tauchi et al. [36], another G-4 inhibitor, telomestatin, could activate the ATM and Chk2, suggesting that telomere dysfunction induced by telomestatin activates the ATM-dependent DNA damage response in human leukemia cells.